Evidence map›Paper›PMID 31506432›Full record

ArticleCell death & disease2019

Degraded neutrophil extracellular traps promote the growth of Actinobacillus pleuropneumoniae.

Nicole de Buhr, Marta C Bonilla, Jessica Pfeiffer, Silke Akhdar, Cornelia Schwennen, Barbara C Kahl, Karl-Heinz Waldmann, Peter Valentin-Weigand, Isabel Hennig-Pauka, Maren von Köckritz-Blickwede

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Journal of oral microbiology · 2026
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Moonlighting chromatin: when DNA escapes nuclear control.Cell death and differentiation · 2023
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Nicole de BuhrDepartment of Physiological Chemistry, University of Veterinary Medicine Hannover, Hannover, Germany. nicole.de.buhr@tiho-hannover.de.ORCID http://orcid.org/0000-0002-4516-7838
Marta C BonillaDepartment of Physiological Chemistry, University of Veterinary Medicine Hannover, Hannover, Germany.
Jessica PfeifferDepartment of Physiological Chemistry, University of Veterinary Medicine Hannover, Hannover, Germany.
Silke AkhdarDepartment of Physiological Chemistry, University of Veterinary Medicine Hannover, Hannover, Germany.
Cornelia SchwennenClinic for Swine, Small Ruminants, Forensic Medicine and Ambulatory Service, University of Veterinary Medicine Hannover, Hannover, Germany.
Barbara C KahlInstitute of Medical Microbiology, University Hospital Münster, Münster, Germany.
Karl-Heinz WaldmannClinic for Swine, Small Ruminants, Forensic Medicine and Ambulatory Service, University of Veterinary Medicine Hannover, Hannover, Germany.
Peter Valentin-WeigandInstitute for Microbiology, University of Veterinary Medicine Hannover, Hannover, Germany.
Isabel Hennig-PaukaField Station for Epidemiology, University of Veterinary Medicine Hannover, Bakum, Germany. Isabel.hennig-pauka@tiho-hannover.de.
Maren von Köckritz-BlickwedeDepartment of Physiological Chemistry, University of Veterinary Medicine Hannover, Hannover, Germany. maren.von.koeckritz-blickwede@tiho-hannover.de.ORCID http://orcid.org/0000-0001-7712-9767
University of Veterinary Medicine Hannover, Foundation · DEUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Actinobacillus pleuropneumoniae (A.pp) causes severe pneumonia associated with enormous economic loss in pigs. Peracute diseased pigs die in <24 h with pneumonia. Neutrophils are the prominent innate immune cell in this infection that massively infiltrate the infected lung. Here we show that neutrophils release neutrophil extracellular traps (NETs) as response to A.pp infection. Numerous NET-markers were identified in bronchoalveolar lavage fluid (BALF) of A.pp-infected piglets in vivo, however, most NET fibers are degraded. Importantly, A.pp is able to enhance its growth rate in the presence of NETs that have been degraded by nucleases efficiently. A.pp itself releases no nuclease, but we identified host nucleases as sources that degrade NETs after A.pp infection. Furthermore, the nucleases of co-infecting pathogens like Streptococcus suis increase growth of A.pp in presence of porcine NETs. Thus, A.pp is not only evading the antimicrobial activity of NETs, A.pp is rather additionally using parts of NETs as growth factor thereby taking advantage of host nucleases as DNase1 or nucleases of co-infecting bacteria, which degrade NETs. This effect can be diminished by inhibiting the bacterial adenosine synthase indicating that degraded NETs serve as a source for NAD, which is required by A.pp for its growth. A similar phenotype was found for the human pathogen Haemophilus (H.) influenzae and its growth in the presence of human neutrophils. H. influenzae benefits from host nucleases in the presence of neutrophils. These data shed light on the detrimental effects of NETs during host immune response against certain bacterial species that require and/or efficiently take advantage of degraded DNA material, which has been provided by host nuclease or nucleases of other co-infecting bacteria, as growth source.

Indexed as

Actinobacillus InfectionsActinobacillus pleuropneumoniaeAnimalsExtracellular TrapsLungPneumonia, BacterialSwineSwine Diseases

Identifiers

PMID31506432
PMCPMC6736959
OpenAlexW2972817358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.